References

• Abbott, R. A. et al. (2010). An Evaluation of the Precision of Measurement of Ryff’s Psychological Well-Being Scales in a Population Sample. Soc Indic Res. 97(3), 357–373
• AHA (2014). American Heart Association Recommendations for Physical Activity in Adults 2014.
  http://www.heart.org/HEARTORG/HealthyLiving/PhysicalActivity/FitnessBasics/American-Heart-Association-Recommendations-for-Physical-Activity-in-Adults_UCM_307976_Article.jsp#.V9bc5jWy-M8.
• Baumeister, Bratslavsky, Finkenauer, & Vohs, (2001). Bad is stronger than good. Review of General Psychology, 5, 323–370.
• Bertisch, Rath, Long, Ashman, & Rashid, (2014). Positive psychology in rehabilitation medicine: A brief report. NeuroRehabilitation. 34(3), 573-85
• Carney, R.M. & Freedland KE. (2009). Treatment-resistant depression and mortality after acute coronary syndrome. Am J Psychiatry. 166, 410–7.
• Carney, R.M. & Freedland, K.E.  (2017). Depression and coronary heart disease. Nat Rev Cardiol. 14(3),145-155.
• Celano, C.M.,& Huffman, J.C. Depression and cardiac disease: a review. (2011). Cardiology in Review. 19(3), 130–142.
• Chaddha, A., Robinson, E.A., Kline-Rogers, E., Alexandris-Souphis, T. & Rubenfire, M. (2016). Mental health and cardiovascular disease. Am J Med.129(11),1145-1148.
• Chauvet-Gelinier, J. C. & Bonin, B. (2017). Stress, anxiety and depression in heart disease patients: A major challenge for cardiac rehabilitation. Annals of Physical and Rehabilitation Medicine 60, 6–12.
• Dekker, R. (2011). Cognitive Therapy for Depression in Patients with Heart Failure: A Critical Review. Heart Fail Clin. 7(1), 127–141.
• DuBois, C. M., Lopez, O. V. Beale, E, E. & Healy, B. C. (2015). Relationships between positive psychological constructs and health outcomes in patients with cardiovascular disease: A systematic review. International Journal of Cardiology, 195, 265-280.
• Fernandez, A., Bang, S.E. & Srivathsan, K, et al. (2007). Cardiovascular side effects of newer antidepressants. Anadolu Kardiyol Derg.7, 305–309.
• Foss-Nieradko, B., Stepnowska, M. & Piotrowicz, R. (2012). Effect of the dynamics of depression symptoms on outcomes after coronary artery bypass grafting. Kardiol Pol. 70(6), 591-7.
• Glanz, K, Rimer, B. & Viswanath.K. (2008). Health behavior and health education: Theory, research and practice. San Francisco, CA: Jossey-Bass.
• Graven, L. J., Grant, J. (2013). The impact of social support on depressive symptoms in individuals with heart failure: update and review. J Cardiovasc Nurs. 28(5), 429-43.
• Green, C.P., Porter, C.B., Bresnahan, D.R. & Spertus, J.A. (2000). Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure, 35(5), 1245-55.
• Glassman, A.H., Bigger, J.T., Gaffney, M., Shapiro, P.A. & Swenson, J.R. (2006). Onset of major depression associated with acute coronary syndromes: relationship of onset, major depressive disorder history, and episode severity to sertraline benefit. Archives of General Psychiatry. 63(3), 283–288
• Glassman, A.H., Roose, S.P. & Bigger, J.T. (1993). The safety of tricyclic antidepressants in cardiac patients: risk-benefit reconsidered. JAMA. 269, 2673–2675.
• Haywood, K.L., et al. (2005) Older People Specific Health Status and Quality of Life: A Structured Review of Self-Assessed Instruments J Eval Clin Pract 11 (4), 315-327.
• Huffman, J. C. et al. (2011). A collaborative care depression management program for cardiac inpatients: Depression characteristics and in-hospital outcomes. Psychosomatics. 52(1), 26–33.
• Huffman, J. C. et al. (2013). Depression and Cardiac Disease: Epidemiology, Mechanisms, and Diagnosis. Cardiovasc Psychiatry Neurol. Published online 2013 Apr 7. doi:  10.1155/2013/695925 PMCID: PMC3638710.
• Jowsey, S. G. et al., (2012). Seligman's theory of attributional style: optimism, pessimism, and quality of life after heart transplant, Prog. Transplant. 22, 49–55.
• Kantor, S.J., Bigger, J.T., Glassman, A.H., et al. (1975). Imipramine-induced heart block. A longitudinal case study. JAMA. 231, 1364–1366.
• Kroenke K., Spitzer R.L., Williams J.B. (2001). The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 16(9):606-13.
• Kroenke K., Spitzer R.L., Williams J.B. (2003) The Patient Health Questionnaire-2: Validity of a Two-Item Depression Screener. Medical Care, (41) 1284-1294.
• Lavin, M.R., Mendelowitz, A., Kronig, M.H. (1993). Spontaneous hypertensive reactions with monoamine oxidase inhibitors. Biol Psychiatry. 34, 146–151.
• Lespérance, F., Frasure-Smith, N., Koszycki, D., et al. (2007). Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: The Canadian cardiac randomized evaluation of antidepressant and psychotherapy efficacy (CREATE) trial. The Journal of the American Medical Association, 297(4),367–379.
• Lichtman, J. H. et al. (2008). Depression and Coronary Heart Disease; Recommendations for Screening, Referral, and Treatment: A Science Advisory From the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: Endorsed by the American Psychiatric Association http://dx.doi.org/10.1161/CIRCULATIONAHA.108.190769 Published: October 21, 2008 retrieved September 16, 2016.
• Luchetti, M., Barkley, J.M., Stephan, Y., Terracciano, A. &  Sutin, A.R. (2014). Five-factor model personality traits and inflammatory markers: new data and a meta-analysis. Psychoneuroendocrinology 50, 181–93.
• Magyar-Russell,G., Thombs, B.D., Cai, J.X., et al.(2011). The prevalence of anxiety and depression in adults with implantable cardioverter defibrillators: a systematic review. Journal of Psychosomatic Research. 71(4), 223–231.
• Martens E.J, de Jonge P., Na B., et al. (2010) Scared to Death? Generalized Anxiety Disorder and Cardiovascular Events in Patients With Stable Coronary Heart DiseaseThe Heart and Soul Study. Arch Gen Psychiatry. 67(7):750-758.
• Maslow, A (1954). Motivation and personality. New York, NY: Harper.
  Mavrides, N. & Nemeroff, C., (2013). Treatment of depression in cardiovascular disease. Depress Anxiety, 30(4),328-41.
• Myaskovsky, L. et al., (2006). Trajectories of change in quality of life in 12-month survivors of lung or heart transplant, Am. J. Transplant. 6, 1939–1947.
• Peterson, C. (2006). A Primer in Positive Psychology. Oxford University Press.
• Player, M.S. and Peterson, L.E. (2011) Anxiety Disorders, Hypertension, and Cardiovascular Risk: A Review. International Journal of Psychiatry in Medicine. 41, 365-377.
• Rogers, C. R. (1961). On Becoming a person: A psychotherapists view of psychotherapy. Houghton Mifflin.
• Rogers, C. R., Stevens, B., Gendlin, E. T., Shlien, J. M., & Van Dusen, W. (1967). Person to person: The problem of being human: A new trend in psychology. Lafayette, CA: Real People Press.
• Roose, S.P., Glassman, A.H., Giardina, E.G., et al. (1987). Tricyclic antidepressants in depressed patients with cardiac conduction disease. Arch Gen Psychiatry. 44, 273–275.
• Rozin, P., & Royzman, E. (2001). Negativity bias, negativity dominance, and contagion. Personality and Social Psychology Review, 5 (4), 296–320.
• Rutledge, T., Reis, V.A, Linke, S.E., Greenberg, B.H. & Mills, P.J. (2006). Depression in heart failure. A meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. Journal of the American College of Cardiology. 48(8), 1527–1537.
• Ryff, C.D. (1995). Psychological well-being in adult life. Current Directions in Psychological Science, 4, 99-104.
• Scheier M.F., Matthews K.A., Owens J.F., Magovern G.J., Lefebvre R.C., Abbott R.A., Carver C.S. Dispositional optimism and recovery from coronary artery bypass surgery: The beneficial effects on physical and psychological well-being. Journal of Personality and Social Psychology. 57, 1024–1040.
• Scherrer et al. (2010). Anxiety disorders increase risk for incident myocardial infarction in depressed and nondepressed Veterans Administration patients. Am Heart J. 159(5):772-9.
• Seligman, M. (2006). Learned Optimism: How to Change Your Mind and Your Life. Vintage.
• Seligman, M. E. P. (2011). Flourish: A visionary new understanding of happiness and well-being. New York, NY: Simon & Schuster.
• Selye H. The stress of life. New-York: McGraw-Hill Book Company, Inc; 1956.
• Slade, M. (2010). Mental illness and well-being: the central importance of positive psychology and recovery approaches. BMC Health Serv Res. 10, 26. doi: 10.1186/1472-6963-10-26.
• Spindelegger, C. l. et al. (2014). Cardiovascular adverse reactions during antidepressant treatment: a drug surveillance report of German-speaking countries between 1993 and 2010. Int J Neuropsychopharmacol. 18(4)
• Taylor, C. B. et al. (2005). Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction. Arch Gen Psychiatry. 62(7),792-8.
• Teply, R.M., Packard, K.A., White, N.D., Hilleman, D.E. & DiNicolantonio, J.J.  (2016). Treatment of depression in patients with concomitant cardiac disease. Prog Cardiovasc Dis. 58, 514–28.
• Tully, P. J. & Baker, R. A., (2012). Depression, anxiety, and cardiac morbidity outcomes after coronary artery bypass surgery: a contemporary and practical review. Journal of Geriatric Cardiology, 9(2)197–208.
• van Montfort, A., Meyer, F.A., von Kanel, R., Saner, H., Schmid, J.P. & Stauber, S.  (2015). Positive affect moderates the effect of negative affect on cardiovascular disease-related hospitalizations and all-cause mortality after cardiac rehabilitation. Eur J Prev Cardiol 22, 1247–53.
• Wimbiscus, M., Kostenko, O. & Malone, D. (2010). MAO inhibitors: risks, benefits, and lore. Cleve Clin J Med. 77,859–882.
• Wu, C. K. et al. (2014). Anti-anxiety drugs use and cardiovascular outcomes in patients with myocardial infarction: a national wide assessment. Atherosclerosis. 235(2), 496-502.
• Zhang, Y., Chen, Y.& Ma, L. (2018). Depression and cardiovascular disease in elderly: Current understanding. J Clin Neurosci. 47,1-5.

© RnCeus.com